# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and lowers the price target from $6 t...
Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.41) by 8...
Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.660) per share which missed the analyst consensus estimate of $(0.280) by...
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...
Elutia Inc. (NASDAQ:ELUT) today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administra...